These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16956087)

  • 41. Galactorrhea After Selective Serotonin Reuptake Inhibitor Use in an Adolescent Girl: A Case Report.
    Kaba D; Öner Ö
    J Clin Psychopharmacol; 2017 Jun; 37(3):374-376. PubMed ID: 28383361
    [No Abstract]   [Full Text] [Related]  

  • 42. Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
    Pallanti S; Koran LM
    Am J Psychiatry; 1999 May; 156(5):796. PubMed ID: 10327919
    [No Abstract]   [Full Text] [Related]  

  • 43. Panic attacks associated with citalopram.
    Brauer HR; Nowicki PW; Catalano G; Catalano MC
    South Med J; 2002 Sep; 95(9):1088-9. PubMed ID: 12356120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

  • 46. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
    Lash TL; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT; Pedersen L
    Acta Oncol; 2010 Apr; 49(3):305-12. PubMed ID: 20156115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.
    Berilgen MS
    J Clin Psychopharmacol; 2010 Dec; 30(6):753-4. PubMed ID: 21057247
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].
    Richard MA; Fiszenson F; Jreissati M; Jean Pastor MJ; Grob JJ
    Ann Dermatol Venereol; 2001; 128(6-7):759-61. PubMed ID: 11460042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escitalopram and ischemic stroke: cause or chance association?
    Aggarwal A; Kumar R; Sharma RC; Sharma DD
    Ann Pharmacother; 2010 Sep; 44(9):1508-9. PubMed ID: 20716693
    [No Abstract]   [Full Text] [Related]  

  • 51. Recurrent hyponatremia after substitution of citalopram with duloxetine.
    Dirks AC; van Hyfte DM
    J Clin Psychopharmacol; 2007 Jun; 27(3):313. PubMed ID: 17502788
    [No Abstract]   [Full Text] [Related]  

  • 52. Escitalopram-Induced Rash.
    Prabhakar D; Sablaban I
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996
    [No Abstract]   [Full Text] [Related]  

  • 53. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Citalopram-induced major depression in a patient with panic disorder - a case report.
    Hofmann P; Conrad R
    Psychiatr Danub; 2012 Mar; 24(1):94-6. PubMed ID: 22447093
    [No Abstract]   [Full Text] [Related]  

  • 55. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escitalopram: a review of its use in the management of major depressive disorder in adults.
    Garnock-Jones KP; McCormack PL
    CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
    Spigset O; Adielsson G
    Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
    [No Abstract]   [Full Text] [Related]  

  • 58. Toxicity with selective serotonin reuptake inhibitors.
    Solomons K; Gooch S; Wong A
    Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
    [No Abstract]   [Full Text] [Related]  

  • 59. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.
    Evans DL; Lynch KG; Benton T; Dubé B; Gettes DR; Tustin NB; Lai JP; Metzger D; Douglas SD
    Biol Psychiatry; 2008 May; 63(9):899-905. PubMed ID: 17945197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.